GGrantIndex
Sort

15,842 grants matching pancreatic cancer

The role of stem cells and the microenvironment in gastrointestinal cancers

$937,650
Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2024 · CA

Preclinical development of TIMP-2 as a biologic therapy for cancer

$936,906
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma

$936,814
Andrei Iagaru · Stanford University · U01 · FY2018 · CA

Computational Tools For Bioinformatics And Genome Analysis

$936,720
John I Powell · Center For Information Technology · ZIA · FY2013 · CT

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$936,650
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2018 · CA

Elucidation and targeting of paracrine cascades in PDAC

$936,242
Kenneth P Olive · Columbia University Health Sciences · U01 · FY2024 · CA

DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs

$935,600
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis

$935,521
Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2008 · CA

Studying factors controlling cancer progression and immune recognition in mouse models

$934,920
Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2023 · CA

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease

$934,873
John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images

$934,447
Debiao Li · Cedars-Sinai Medical Center · R01 · FY2023 · CA

Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy

$934,438
Lei Zhu · Migra-Therapeutics, Llc · R44 · FY2022 · CA

Studies of Rare Cancers

$934,284
Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Tissue factor-dependent coagulation in thrombosis and immune responses

$933,000
Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2022 · HL

Tissue factor-dependent coagulation in thrombosis and immune responses

$933,000
Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2025 · HL

Tissue factor-dependent coagulation in thrombosis and immune responses

$933,000
Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2023 · HL

New Ways of Targeting K-Ras

$932,874
Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2016 · CA

Plasmonic Scattering Microscopy for high-throughput in-situ quantification of molecular binding kinetics on single cells

$932,810
Nguyen Ly · Biosensing Instrument, Inc. · R42 · FY2025 · GM

Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment

$932,376
Bumsoo Han · University Of Illinois At Urbana-Champaign · U01 · FY2025 · CA

Using markers to improve pancreatic cancer screening and surveillance

$931,728
Michael G. Goggins · Johns Hopkins University · U01 · FY2021 · CA

Mechanisms governing metastatic dormancy and reactivation

$931,198
Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · CA

Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors

$930,607
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Using markers to improve pancreatic cancer screening and surveillance

$930,050
Michael G. Goggins · Johns Hopkins University · U01 · FY2020 · CA

Comprehensive Cancer Center Core Support Grant

$930,000
Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2010 · CA

Live-cell Activity Architecture in Cancer

$929,040
Jin Zhang · University Of California, San Diego · R35 · FY2023 · CA